Abstract
(Anesth Analg. 2022;134:634–632) Cervical cerclage, an operation designed to reduce preterm delivery and improve perinatal outcomes, is often performed under spinal anesthesia. While the benefits of spinal anesthesia are well documented, a short-acting local anesthetic agent, such as 2-chloroprocaine, could shorten postanesthesia care unit (PACU) stay compared with longer acting agents. Currently, bupivacaine is the most used local anesthesia for cerclage because of historical concern regarding 2-chloroprocaine’s safety. This study randomly compared the outcome of 2-chloroprocaine 3% 50 mg and hyperbaric bupivacaine 0.75% 9 mg on dermatomal level, sensory block resolution, ability to ambulate and void, and motor blockade.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
